AB Large Cap Value A holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
AB Large Cap Value Fund Class A ABVAX
- NAV / 1-Day Return 21.01 / −0.71 %
- Total Assets 525.1M
-
Adj. Expense Ratio
0.890%
- Expense Ratio 0.890%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.93%
- Turnover 48%
USD | NAV as of Jun 18, 2026 | 1-Day Return as of Jun 18, 2026, 12:11 AM GMT+0
Morningstar’s Analysis ABVAX
Will ABVAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the ABVAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of ABVAX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Alphabet Inc Class C | 4.02 | 20M | Communication Services |
Exxon Mobil Corp | 3.87 | 20M | Energy |
Walmart Inc | 3.26 | 16M | Consumer Defensive |
Bank of America Corp | 3.03 | 15M | Financial Services |
Lam Research Corp | 3.00 | 15M | Technology |
RTX Corp | 2.96 | 15M | Industrials |
The Walt Disney Co | 2.84 | 14M | Communication Services |
UnitedHealth Group Inc | 2.57 | 13M | Healthcare |
American Electric Power Co Inc | 2.56 | 13M | Utilities |
Merck & Co Inc | 2.56 | 13M | Healthcare |
United States